Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Cash & Equivalents: 2012-2024

Historic Cash & Equivalents for MediWound (MDWD) over the last 12 years, with Dec 2024 value amounting to $9.2 million.

  • MediWound's Cash & Equivalents rose 405.59% to $32.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.7 million, marking a year-over-year increase of 405.59%. This contributed to the annual value of $9.2 million for FY2024, which is 22.85% down from last year.
  • Latest data reveals that MediWound reported Cash & Equivalents of $9.2 million as of FY2024, which was down 22.85% from $11.9 million recorded in FY2023.
  • MediWound's Cash & Equivalents' 5-year high stood at $33.9 million during FY2022, with a 5-year trough of $9.2 million in FY2024.
  • For the 3-year period, MediWound's Cash & Equivalents averaged around $18.3 million, with its median value being $11.9 million (2023).
  • As far as peak fluctuations go, MediWound's Cash & Equivalents spiked by 206.85% in 2022, and later slumped by 64.99% in 2023.
  • Over the past 5 years, MediWound's Cash & Equivalents (Yearly) stood at $17.4 million in 2020, then plummeted by 36.43% to $11.0 million in 2021, then surged by 206.85% to $33.9 million in 2022, then slumped by 64.99% to $11.9 million in 2023, then fell by 22.85% to $9.2 million in 2024.